Diagnostic accuracy of noninvasive polymerase chain reaction testing for the determination of fetal rhesus C, c and e status in early pregnancy

BJOG: An International Journal of Obstetrics and Gynaecology

Volumn 117, Issue 6, 2010, Pages 722-729

  Gutensohn, K ^a   Müller, Sp ^b   Thomann, K ^b   Stein, W ^b   Suren, A ^c   Kortge Jung S ^d   Schluter G ^e   Legler, Tj ^b  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b UNIVERSITY OF GÖTTINGEN   (Germany)

^c Center for Gynecology and Obstetrics   (Germany)

^d Pränatal Medizin und Genetik ^*  (Germany)

^e Versorgungszentrum   (Germany)

Author keywords

Genotyping; Maternal; Polymerase chain reaction; RHCE gene; Sensitivity; Specificity

Indexed keywords

BLOOD GROUP E ANTIGEN; DNA; RHESUS ANTIGEN;

ADULT; ALLELE; AMNION FLUID ANALYSIS; ANTIGEN DETECTION; ARTICLE; BLOOD EXAMINATION; BLOOD GROUP RHESUS SYSTEM; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DNA EXTRACTION; FEMALE; FETUS; FIRST TRIMESTER PREGNANCY; GENOTYPE; GESTATIONAL AGE; HUMAN; LABORATORY DIAGNOSIS; MATERNAL PLASMA; POLYMERASE CHAIN REACTION; PREGNANT WOMAN; PRENATAL PERIOD; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY;

ADOLESCENT; ADULT; FEMALE; GENETIC MARKERS; GENOTYPE; HUMANS; MIDDLE AGED; PHENOTYPE; POLYMERASE CHAIN REACTION; PREGNANCY; PREGNANCY TRIMESTER, FIRST; PREGNANCY TRIMESTER, SECOND; PRENATAL DIAGNOSIS; RH ISOIMMUNIZATION; RH-HR BLOOD-GROUP SYSTEM; SENSITIVITY AND SPECIFICITY; YOUNG ADULT;

EID: 77950665658     PISSN: 14700328     EISSN: 14710528     Source Type: Journal    
DOI: 10.1111/j.1471-0528.2010.02518.x     Document Type: Article

References (33)

1. Avent ND, Reid M. The Rh blood group system. Blood 2000 95 : 375 387.
2. Bowman JM. RhD hemolytic disease of the newborn. N Engl J Med 1998 339 : 1775 1777.
3. Eder A. Update on HDFN: new information on long-standing controversies. Immunohematology 2006 22 : 188 195. (Pubitemid 46239723)
4. Urbaniak S, Greiss S. RhD haemolytic disease of the fetus and the newborn. Blood Rev 2000 14 : 44 61. (Pubitemid 30216168)
5. Daniels G. Blood group antibodies in haemolytic disease of the fetus and newborn. In : Hadley A, Soothill P, editors. Alloimune Disorders of Pregnancy.
6. Moise KJ. Non-anti-D antibodies in red-cell alloimmunization. Eur J Obstet Gynecol Reprod Biol 2000 92 : 75 81.
7. Poissonier MH, Brossard Y, Demeideros N, Vassileva J, Parnet F, Larsen M, et al. Two hundred intrauterine exchange transfusions in severe blood incompatibilities. Am J Obstet Gynecol 1989 161 : 709 713. (Pubitemid 19252791)
8. Daniels G, Finning KM, Martin PG, Soothill P. Fetal blood group genotyping from DNA from maternal plasma. An important advance in the management and prevention of haemolytic disease of the fetus and newborn. Vox Sang 2004 87 : 225 232. (Pubitemid 39627149)
9. Finning KM, Martin PG, Soothill PW, Avent ND. Prediction of fetal D status from maternal plasma: introduction of a new noninvasive fetal RHD genotyping service. Transfusion 2002 42 : 1079 1085.
10. Lo YM, Hjelm NM, Fidler C, Sargent IL, Murphy MF, Chamberlain PF, et al. Prenatal diagnosis of fetal RhD status by molecular analysis of maternal plasma. N Engl J Med 1998 339 : 1734 1738. (Pubitemid 28555431)
11. van der Schoot CE, Hahn S, Chitty LS. Non-invasive prenatal diagnosis and determination of fetal Rh status. Semin Fetal Neonatal Med 2008 13 : 63 8.
12. Finning K, Martin P, Summers J, Daniels G. Fetal genotyping for the K (Kell) and Rh C, c, and E blood groups on cell-free fetal DNA in maternal plasma. Transfusion 2007 47 : 2126 2133. (Pubitemid 47623982)
13. Hromadnikova I, Vesela K, Benesova B, Nekovarova K, Duskova D, Vlk R, et al. Non-invasive fetal RHD and RHCE genotyping from maternal plasma in alloimmunized pregnancies. Prenat Diagn 2005 25 : 1079 1083. (Pubitemid 43016285)
14. Legler TJ, Lynen R, Maas J-H, Pindur G, Kulenkampff D, Suren A, et al. Prediction of fetal Rh D and Rh CcEe phenotype from maternal plasma with real-time polymerase chain reaction. Transfus Apher Sci 2002 27 : 217 223. (Pubitemid 35341658)
15. Orzinska A, Guz K, Brojer E, Zupanska B. Preliminary results with fetal RHc examination in plasma of pregnant women with anti-c. Prenat Diagn 2009 28 : 335 337. (Pubitemid 351519073)
16. Greifman-Holtzman O, Grotegut CA, Gaughan JP, Holtzman EJ, Floro C, Hernandez E. Noninvasive fetal RhCE genotyping from maternal blood. BJOG 2008 116 : 144 151.
17. Müller SP, Bartels I, Stein W, Emons G, Gutensohn K, Köhler M. The determination of the fetal D status from maternal plasma for decision making on Rh prophylaxis is feasible. Transfusion 2008 48 : 2292 2301.
18. Chiu RW, Poon L, Lau TK, Leung TN, Wong EM, Lo YM. Effects of blood-processing protocols on fetal and total DNA quantification in maternal plasma. Clin Chem 2001 47 : 1607 1613. (Pubitemid 32781573)
19. Legler TJ, Zhong L, Heermann K-H, Hempel M, Gutensohn K, Kiesewetter H, et al. Specific magnetic bead-based capture of free fetal DNA from maternal plasma. Transfus Apher Sci 2009 40 : 153 157.
20. Daniels G, Finning KM, Martin PG, Summers J. Fetal blood group genotyping: present and future. Ann N Y Acad Sci 2006 1075 : 88 95. (Pubitemid 44532769)
21. Westhoff CM. Molecular testing for transfusion medicine. Curr Opin Hematol 2009 13 : 471 475.
22. Chavez GF, Mulinare J, Edmonds LD. Epidemiology of Rh hemolytic disease of the newborn in the United States. J Am Med Assoc 2009 2651 : 3270 3274.
23. Mollison PL, Engelfriet CP, Contreras M Haemolytic disease of the fetus and the newborn. In : Mollison PL, Engelfriet CP, Conteras M, editors. Blood Transfusion in Clinical Medicine, 10th edn.
24. Koelewijn JM, Vrijkotte TG, van der Schoot CE, Bonsel GJ, de Haas M. Effect of screening for red cell antibodies, other than anti-D, to detect hemolytic disease of the fetus and newborn: a population study in the Netherlands. Transfusion 2008 48 : 941 952.
25. Moise KJ. Red blood cell alloimmunization in pregnancy. Semin Hematol 2005 42 : 169 178.
26. Picchiassi E, Coata G, Fanetti A, Centra M, Pennacchi L, Di Renzo GC. The best approach for early prediction of fetal gender by using free fetal DNA from maternal plasma. Prenat Diagn 2009 28 : 525 530.
27. Chan KC, Ding C, Gerovassili A, Yeung SW, Chiu RWK, Leung TN, et al. Hypermethylated RASSFIA in maternal plasma: a universal fetal DNA marker that improves the reliability of noninvasive prenatal diagnosis. Clin Chem 2009 52 : 2211 2218.
28. Mouro I, Colin Y, Chérif-Zahar B, Cartron J-P, Kim CLV. Molecular genetic basis of the human rhesus blood group system. Nat Genet 1993 5 : 62 5.
29. Chan K, Zhang J, Hui A, Wong N, Lau T, Leung T, et al. Size distributions of maternal and fetal DNA in maternal plasma. Clin Chem 2004 50 : 88 92. (Pubitemid 38125703)
30. Grooterk-Tax M, Soussan A, de Haas M, Maaskant-van Wijk P, van der Schoot CE. Evaluation of prenatal RHD typing strategies on cell-free fetal DNA from maternal plasma. Transfusion 2006 46 : 2142 2148.
31. Ding C. MALDI-TOF mass spectrometry for analyzing cell-free DNA in maternal plasma. Methods Mol Biol 2008 444 : 253 267.
32. Li Y, Finning K, Daniels G, Hahn S, Zhong X, Holzgreve W. Noninvasive genotyping fetal Kell blood group (KEL1) using cell-free fetal DNA in maternal plasma by MALDI-TOF mass spectrometry. Prenat Diagn 2008 28 : 203 208.
33. Zhong XY, Holzgreve W. MALDI-TOF MS in prenatal genomics. Tranfus Med Hemother 2009 36 : 263 272.